Yulin Yuan

Wuhan University of Science and Technology

Papers

1

Total Citations

2

H-Index

1

About

Dr. Yulin Yuan is a leading surgical oncologist whose research focuses on optimizing surgical approaches for hepatocellular carcinoma (HCC), particularly through comparative effectiveness studies of minimally invasive techniques. His most cited work, a 2025 nationwide cohort study examining clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection for BCLC 0/A HCC, has already garnered significant attention with 2 citations shortly after publication. This landmark investigation provides crucial evidence on the trade-offs between surgical modalities, addressing long-standing debates about optimal treatment strategies for early-stage liver cancer. Dr. Yuan’s research uniquely combines clinical outcomes with economic analysis, offering a comprehensive framework for decision-making in hepatobiliary surgery. His work has direct implications for surgical practice, helping to guide the adoption of robotic and laparoscopic approaches while considering both patient outcomes and healthcare costs. Through rigorous population-level analyses, Dr. Yuan continues to shape evidence-based surgical oncology, making him a valuable resource for clinicians and researchers navigating the evolving landscape of minimally invasive liver surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Clinical and economic outcomes of robotic-assisted, laparoscopic, and open liver resection in BCLC 0/A hepatocellular carcinoma: a nationwide cohort study
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Wuhan University of Science and Technology

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago